NextPharma inaugurates new production facility for liquid pharmaceuticals in Limay, France
"This project reflects our commitment to bringing the production of essential medicines back to France..."
Advertisement
NextPharma announces the inauguration ceremony of its new liquid pharmaceutical production plant at the Limay site (Yvelines, 78) on September 12, 2025. The new plant is the result of the NextFly project, which is part of the French government's strategic plan for the reshoring of essential medicines production, presented on January 6, 2025. Supported by the France 2030 initiative, this investment strengthens NextPharma's role in promoting national health sovereignty and industrial innovation.
NextPharma GmbH
The new facility at NextPharma's center of excellence in Limay specializes in the production of non-sterile liquid pharmaceuticals, including levetiracetam, an important drug for the treatment of epilepsy. The expansion doubled the site's production capacity and supports NextPharma's corporate strategy of increasing competitiveness while maintaining the highest international quality standards.
"The inauguration of our new production facility marks a milestone for NextPharma Limay," explains Bertrand PIHA, Site Manager. "This project reflects our commitment to bring the production of essential medicines back to France and to strengthen national health sovereignty. We have actively involved local and national partners to promote skills development and employment. We are thus making a proud contribution to the economic regeneration of the Grand Paris Seine & Oise region."
Partners, customers and institutional representatives are expected to attend the inauguration. The program includes a guided tour of the new facility, official speeches and a cocktail lunch afterwards.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Most read news
Other news from the department manufacturing
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Spanish startup receives investment for novel disinfection method against “killer fungus” - The UJI spin-off Molecular Sustainable Solutions receives an investment from BeAble Capital to boost its disinfection and sterilization methods
Merck Opens Climate-Neutral €150 Million Manufacturing Facility in Ireland - The Blarney Business Park facility is part of Merck’s largest Life Science investment to date
Simtra BioPharma Solutions expands U.S. manufacturing capacity for injectable medicines - Simtra positioned to become the first CDMO to offer commercial-scale drug product manufacturing of antibody-drug conjugates in the United States
CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE
ChatGPT grows insect-toxic genetically engineered plant - Blind spot in the EU draft law on genetic engineering
Commission launches new strategy to make Europe a global leader in life sciences by 2030
CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - BioNTech’s acquisition of CureVac will be implemented as planned
Ibidi Awarded With the German bAV Prize 2023
Using AI as an exam tutor - Artificial intelligence is set to help human examinees study more effectively
EXIST start-up grant for virtual reality laboratory training - "Wet-Lab-VR": Virtual reality technology revolutionises training for molecular biology laboratories
Sustainable Plastics from Plants - Innovative interdisciplinary education model